Literature DB >> 1777371

A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects.

G Yu1, V Maskray, S H Jackson, C G Swift, B Tiplady.   

Abstract

1. The effects of oral administration of 250 mg caffeine or theophylline and placebo on subjective ratings and psychological test performance were studied in a double-blind crossover experiment in 20 healthy elderly subjects. 2. Performance on the continuous attention task showed a significant improvement compared with placebo with both active treatments. Performance with caffeine was significantly better than with theophylline. Mean error index scores (normalised AUCs) were: placebo--0.130; caffeine--0.083; theophylline--0.093. No other objective measure shows significant treatment effects. 3. Subjective ratings showed that subjects felt significantly more alert on caffeine than on either theophylline or placebo. Subjects also rated themselves as more energetic and interested on caffeine than on placebo. 4. Plasma concentrations of caffeine were lower than those of theophylline (mean 5.76 and 8.72 mg l-1 respectively at 2 h post-drug. 5. These results suggest that caffeine is a more potent CNS stimulant than theophylline.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777371      PMCID: PMC1368528          DOI: 10.1111/j.1365-2125.1991.tb03909.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  A SIMPLIFIED PAIRED-ASSOCIATE TEST FOR ELDERLY HOSPITAL PATIENTS.

Authors:  B ISAACS; F A WALKEY
Journal:  Br J Psychiatry       Date:  1964-01       Impact factor: 9.319

2.  A comparison of the CNS effects of enprofylline and theophylline in healthy subjects assessed by performance testing and subjective measures.

Authors:  B Tiplady; D Fagan; M Lamont; M Brockway; D B Scott
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

3.  A continuous attention test for the assessment of the acute behavioral effects of drugs.

Authors:  B Tiplady
Journal:  Psychopharmacol Bull       Date:  1988

4.  The effects of age on the response to caffeine.

Authors:  C G Swift; B Tiplady
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  The bronchodilator effects and pharmacokinetics of caffeine in asthma.

Authors:  A B Becker; K J Simons; C A Gillespie; F E Simons
Journal:  N Engl J Med       Date:  1984-03-22       Impact factor: 91.245

6.  The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects.

Authors:  M Bruce; N Scott; M Lader; V Marks
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

7.  Comparison of scoring methods for tests of attention, including an error index for use with schizophrenic patients.

Authors:  R M Pigache
Journal:  Percept Mot Skills       Date:  1976-02

8.  Theophylline antagonizes diazepam-induced psychomotor impairment.

Authors:  S A Henauer; L E Hollister; H K Gillespie; F Moore
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Comparative pharmacokinetics of caffeine in young and elderly men.

Authors:  J Blanchard; S J Sawers
Journal:  J Pharmacokinet Biopharm       Date:  1983-04

10.  Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism.

Authors:  R D Spealman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more
  9 in total

1.  Assessment of changes in psychomotor performance of elderly subjects.

Authors:  L Kalra; S H Jackson; C G Swift
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

Review 2.  Cognition enhancers in age-related cognitive decline.

Authors:  W J Riedel; J Jolles
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

Review 3.  Stimulant drugs and vigilance performance: a review.

Authors:  H S Koelega
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 4.  Attention, psychomotor functions and age.

Authors:  Konrad Wolfgang Kallus; Jeroen A J Schmitt; David Benton
Journal:  Eur J Nutr       Date:  2005-12       Impact factor: 5.614

5.  Computerised psychomotor performance testing: a comparative study of the single dose pharmacodynamics of minaprine and amitriptyline in young and elderly subjects.

Authors:  M T Kinirons; S H Jackson; L Kalra; R T Trevit; C G Swift
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

Review 6.  Caffeine and the elderly.

Authors:  L K Massey
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

Review 7.  Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.

Authors:  Laura López-Cruz; John D Salamone; Mercè Correa
Journal:  Front Pharmacol       Date:  2018-06-01       Impact factor: 5.810

8.  A randomised placebo-controlled trial to differentiate the acute cognitive and mood effects of chlorogenic acid from decaffeinated coffee.

Authors:  David A Camfield; Beata Y Silber; Andrew B Scholey; Karen Nolidin; Antionette Goh; Con Stough
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

Review 9.  Xanthine scaffold: scope and potential in drug development.

Authors:  Nivedita Singh; Ashwinee Kumar Shreshtha; M S Thakur; Sanjukta Patra
Journal:  Heliyon       Date:  2018-10-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.